SciELO - Scientific Electronic Library Online

 
vol.25 issue2Ejemplo de un medicamento probiótico: Saccharomyces boulardii liofilizadaReporte de casos de Fasciolosis en el Instituto Especializado de Salud del Niño, Lima - Perú (1988-2003) author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de Gastroenterología del Perú

Print version ISSN 1022-5129

Abstract

OTERO REGINO, William  and  GOMEZ ZULETA, Martín. Sindrome de Intestino Irritable: diagnóstico y tratamiento farmacológica Revisión concisa. Rev. gastroenterol. Perú [online]. 2005, vol.25, n.2, pp.189-197. ISSN 1022-5129.

Irritable bowel syndrome (IBS) usually is considered a functional gastrointestinal disorder characterized by pain, bloating and either diarrhea or constipation, but a small subgroup of patients report a sudden onset of their IBS symptoms after gastroenteritis, that is named postinfectious IBS. IBS can be diagnosed with confidence when a patient fulfills the Rome II criteria for IBS and displays no warning signs, as determined by a careful history and physical examination. In the past numerous test were considered routine for patients with suspected IBS, however, available data do not support this approach. The etiology of IBS remains unknown and therefore the treatment is focused on relieving symptoms rather than curing the disease. The patient main complaints such as constipation, diarrhea or bloating-pain-gas, determine the therapies of choice, according the severity of them.

Keywords : IBS; postinfectious IBS; diagnosis; treatment; tegaserod; antispasmodic agents; alosetron.

        · abstract in Spanish     · text in Spanish